Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 20, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Robotic-assisted radical cystectomy: current technique and outcomes.

Peter L Steinberg1, Reza Ghavamian

  • 1Maine Medical Partners Urology, 100 Brickhill Ave, S. Portland, ME 04106, USA.

Expert Review of Anticancer Therapy
|August 1, 2012
PubMed
Summary

Robotic-assisted radical cystectomy shows short-term oncologic outcomes similar to open surgery for bladder cancer. While complications are lower and blood loss reduced, long-term data and cost-effectiveness require further investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial Commentary.

Urology practice·2026
Same author

Editorial Comment.

The Journal of urology·2026
Same author

Editorial Commentary.

Urology practice·2025
Same author

Editorial Comment.

The Journal of urology·2025
Same author

Editorial Comment.

Urology practice·2024
Same author

Editorial Commentary.

Urology practice·2024

Area of Science:

  • Urology
  • Surgical Oncology
  • Robotic Surgery

Background:

  • Muscle-invasive bladder cancer management often involves radical cystectomy.
  • Robotic-assisted radical cystectomy (RARC) is an evolving surgical approach.
  • Previous concerns included the extent of lymph node dissection and complication rates.

Purpose of the Study:

  • To evaluate the current status and outcomes of robotic-assisted radical cystectomy.
  • To compare RARC with traditional open radical cystectomy.

Main Methods:

  • Comparative analysis of oncologic outcomes.
  • Assessment of complication rates, blood loss, and transfusion requirements.
  • Evaluation of hospital length of stay and cost implications.

Related Experiment Videos

Last Updated: May 20, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Main Results:

  • Short-term oncologic outcomes for RARC appear comparable to open radical cystectomy.
  • Robotic technology now enables a pelvic lymph node dissection extent similar to open surgery.
  • RARC demonstrates favorable complication rates, reduced blood loss, and lower transfusion rates compared to open surgery.
  • Length of stay may be shortened with RARC, though not consistently reported.
  • Robotic assistance is associated with increased procedural costs.

Conclusions:

  • Robotic-assisted radical cystectomy is a viable surgical option for muscle-invasive bladder cancer with promising short-term results.
  • Further long-term follow-up studies are necessary to fully establish the oncologic efficacy of RARC.
  • While RARC offers advantages in complications and blood loss, its higher cost is a consideration.